SCHEMBL25519632

SCHEMBL25519632

Cc1cc(N)nn1C1CCCO1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
LMNA P02545 2/20 0.54
POLB P06746 2/20 0.54
GAA P10253 1/20 0.52
CYP4F2 P78329 2/20 0.40
CYP4A11 Q02928 2/20 0.40
KMT2A Q03164 3/20 0.38
MEN1 O00255 2/20 0.38
TP53 P04637 1/20 0.38
CYP2C9 P11712 1/20 0.38
NFKB1 P19838 1/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
APEX1 P27695 1/20 0.38
PI4KA P42356 1/20 0.38
BLM P54132 1/20 0.38
ADCY1 Q08828 1/20 0.38
PI4K2B Q8TCG2 1/20 0.38
PI4K2A Q9BTU6 1/20 0.38
PI4KB Q9UBF8 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3500980 0.95 ALDH1A1 (0.49) ALDH1A1LMNAPOLBGAACYP4F2
SCHEMBL14726450 0.79 GAA (0.47) ALDH1A1LMNAPOLBGAACYP4F2
SCHEMBL19204921 0.76 CYP4F2 (0.44) ALDH1A1LMNAPOLBGAACYP4F2
SCHEMBL22449667 0.76 CYP4F2 (0.44) ALDH1A1LMNAPOLBGAACYP4F2
SCHEMBL21187504 0.75 RET (0.49) ALDH1A1LMNAPOLBGAACYP4F2
SCHEMBL21191295 0.75 CYP4F2 (0.43) ALDH1A1LMNAPOLBGAACYP4F2
SCHEMBL31510943 0.75 ALDH1A1 (0.48) ALDH1A1LMNAPOLBGAACYP4F2
SCHEMBL3500250 0.75 CYP4F2 (0.41) ALDH1A1LMNAPOLBGAACYP4F2
SCHEMBL31052495 0.74 HPGD (0.43) ALDH1A1GAAHSD17B10PI4KBESR1
SCHEMBL14638243 0.74 CYP4F2 (0.43) ALDH1A1LMNAPOLBGAACYP4F2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230142274-A1 SUBSTITUTED ARYL COMPOUND NANJING ZAIMING PHARMACEUTICAL CO., LTD. (CN) 2023-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230142274-A1 SUBSTITUTED ARYL COMPOUND RAD51, FANCI, BLM ALDH1A1 2893/4885LMNA 1019/4885POLB 190/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.